Caribou Biosciences(CRBU)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CRBU Caribou Biosciences

盘后交易 10-05 16:50:28 EDT

1.19

-0.03

-2.46%

盘后1.19

+0.000.00%

16:15 EDT

最高1.24	最低1.17	成交量154.62万
今开1.22	昨收1.22	日振幅5.74%
总市值1.27亿	流通市值1.22亿	总股本1.07亿
成交额185.92万	换手率1.51%	流通股本1.02亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CRBU","market":"US","secType":"STK","nameCN":"Caribou Biosciences","latestPrice":1.19,"timestamp":1791230400000,"preClose":1.22,"halted":0,"volume":1546203,"hourTrading":{"tag":"盘后","latestPrice":1.19,"preClose":1.19,"latestTime":"16:15 EDT","volume":3264,"amount":3884.16,"timestamp":1791231300249,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.024590163934426253,"floatShares":102158884,"shares":107000000,"eps":-1.075091,"marketStatus":"盘后交易","change":-0.03,"latestTime":"10-05 16:50:28 EDT","open":1.22,"high":1.24,"low":1.17,"amount":1859223,"amplitude":0.057377,"askPrice":1.41,"askSize":200,"bidPrice":1.17,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.075091,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791244800000},"marketStatusCode":4,"adr":0,"listingDate":1627012800000,"exchange":"NASDAQ","adjPreClose":1.22,"preHourTrading":{"tag":"盘前","latestPrice":1.22,"preClose":1.22,"latestTime":"09:29 EDT","volume":6813,"amount":8557.6212612,"timestamp":1791206999999,"change":0,"changeRate":0,"amplitude":0.032705},"postHourTrading":{"tag":"盘后","latestPrice":1.19,"preClose":1.19,"latestTime":"16:15 EDT","volume":3264,"amount":3884.16,"timestamp":1791231300249,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.005581,"impliedVol":2.8671,"impliedVolPercentile":0.9602},"requestUrl":"/m/hq/s/CRBU","defaultTab":"news","newsList":[{"id":"2518778948","title":"Caribou Biosciences(CRBU.US)：2024年Q4财报实现营收207.7万美元，前值为355.8万美元，预期值为184万美元；每股收益为-0.39美元，前值为-0.39美元，预期值为-0.42美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518778948","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518778948?lang=zh_cn&edition=full","pubTime":"2025-03-11 05:45","pubTimestamp":1741643101,"startTime":"0","endTime":"0","summary":"Caribou Biosciences(CRBU.US)：2024年Q4财报实现营收207.7万美元，前值为355.8万美元，预期值为184万美元；每股收益为-0.39美元，前值为-0.39美元，预期值为-0.42美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11054548643209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CRBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196872356","title":"Caribou生物科学公司2024年第四季度GAAP每股收益$(0.39)，超出预期$(0.42)，销售额$2.08M，未达预期$2.11M","url":"https://stock-news.laohu8.com/highlight/detail?id=1196872356","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196872356?lang=zh_cn&edition=full","pubTime":"2025-03-11 04:14","pubTimestamp":1741637684,"startTime":"0","endTime":"0","summary":"Caribou生物科学公司报告季度每股亏损$，比分析师普遍预期的$高7.14%。该公司报告季度销售额为$208万美元，未达分析师普遍预期的$211万美元，差距为1.39%。这比去年同期的$356万美元下降了41.62%。以上内容来自Benzinga Earnings专栏，原文如下：$Caribou Biosciences$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 7.14 percent. This is unchanged from the same period last year.  The company reported quarterly sales of $2.08 million which missed the analyst consensus estimate of $2.11 million by 1.39 percent.  This is a 41.62 percent decrease over sales of ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Caribou生物科学公司2024年第四季度GAAP每股收益$(0.39)，超出预期$(0.42)，销售额$2.08M，未达预期$2.11M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518820578","title":"Caribou Biosciences, Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518820578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518820578?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:58","pubTimestamp":1741625882,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时58分，Caribou Biosciences, Inc.股票出现波动，股价急速跳水5.08%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.86%。Caribou Biosciences, Inc.公司简介：Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats  生物制药公司，致力于通过应用其新型 CRISPR 平台， CRISPR 杂交 RNA-DNA  来改变患有毁灭性疾病患者的生活，以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311005802abf347a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311005802abf347a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CRBU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517398387","title":"Caribou Biosciences, Inc.盘中异动 下午盘股价大涨5.14%报1.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517398387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517398387?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:26","pubTimestamp":1741116374,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日03时26分，Caribou Biosciences, Inc.股票出现异动，股价大幅上涨5.14%。截至发稿，该股报1.13美元/股，成交量99.5745万股，换手率1.10%，振幅10.09%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Caribou Biosciences, Inc.公司简介：Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats  生物制药公司，致力于通过应用其新型 CRISPR 平台， CRISPR 杂交 RNA-DNA  来改变患有毁灭性疾病患者的生活，以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305032614abe84144&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305032614abe84144&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","CRBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516654565","title":"Caribou Biosciences, Inc.盘中异动 大幅跳水5.13%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516654565","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516654565?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:18","pubTimestamp":1741025929,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时18分，Caribou Biosciences, Inc.股票出现异动，股价快速跳水5.13%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4364.36%、190.31%、179.16%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040218499637e0fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040218499637e0fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","CRBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514361862","title":"Caribou Biosciences, Inc.盘中异动 股价大跌5.24%报1.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514361862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514361862?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:11","pubTimestamp":1740600700,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时11分，Caribou Biosciences, Inc.股票出现异动，股价急速跳水5.24%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.78%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6793.62%、321.58%、263.67%，振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为194.07%、81.11%、70.39%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227041140a2554242&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227041140a2554242&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","CRBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514781019","title":"Caribou Biosciences, Inc.盘中异动 早盘股价大跌6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514781019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514781019?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:13","pubTimestamp":1740500039,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时13分，Caribou Biosciences, Inc.股票出现波动，股价急速下挫6.25%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。Caribou Biosciences, Inc.公司简介：Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats  生物制药公司，致力于通过应用其新型 CRISPR 平台， CRISPR 杂交 RNA-DNA  来改变患有毁灭性疾病患者的生活，以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226001359a2539e83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226001359a2539e83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","CRBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513133372","title":"Caribou Biosciences, Inc.盘中异动 急速跳水5.32%报1.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513133372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513133372?lang=zh_cn&edition=full","pubTime":"2025-02-22 01:35","pubTimestamp":1740159331,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日01时35分，Caribou Biosciences, Inc.股票出现波动，股价大幅下挫5.32%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Caribou Biosciences, Inc.公司简介：Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats  生物制药公司，致力于通过应用其新型 CRISPR 平台， CRISPR 杂交 RNA-DNA  来改变患有毁灭性疾病患者的生活，以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222013531a24ed815&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222013531a24ed815&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CRBU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512166417","title":"Caribou Biosciences, Inc.盘中异动 早盘大幅拉升5.13%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512166417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512166417?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:50","pubTimestamp":1739890216,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时50分，Caribou Biosciences, Inc.股票出现异动，股价快速上涨5.13%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.96%。Caribou Biosciences, Inc.公司简介：Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats  生物制药公司，致力于通过应用其新型 CRISPR 平台， CRISPR 杂交 RNA-DNA  来改变患有毁灭性疾病患者的生活，以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822501696279b4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822501696279b4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","CRBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511692936","title":"Caribou Biosciences, Inc.盘中异动 急速拉升5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511692936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511692936?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:46","pubTimestamp":1739547988,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时46分，Caribou Biosciences, Inc.股票出现波动，股价急速上涨5.34%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Caribou Biosciences, Inc.公司简介：Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats  生物制药公司，致力于通过应用其新型 CRISPR 平台， CRISPR 杂交 RNA-DNA  来改变患有毁灭性疾病患者的生活，以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214234629abcf17ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214234629abcf17ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CRBU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510007336","title":"Caribou Biosciences, Inc.盘中异动 早盘股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510007336","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510007336?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:55","pubTimestamp":1739289358,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时55分，Caribou Biosciences, Inc.股票出现异动，股价急速下挫5.30%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.80%。其相关个股中，Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.、Dominari Holdings Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2750.67%、1186.20%、389.74%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.，振幅分别为58.60%、57.43%、40.87%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211235558abcb18c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211235558abcb18c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","CRBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508141795","title":"Caribou Biosciences, Inc.盘中异动 早盘大幅跳水5.24%报1.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508141795","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508141795?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:49","pubTimestamp":1738594163,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时49分，Caribou Biosciences, Inc.股票出现异动，股价快速跳水5.24%。截至发稿，该股报1.36美元/股，成交量23.6856万股，换手率0.26%，振幅3.85%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Caribou Biosciences, Inc.公司简介：Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats  生物制药公司，致力于通过应用其新型 CRISPR 平台， CRISPR 杂交 RNA-DNA  来改变患有毁灭性疾病患者的生活，以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224923a2380dd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224923a2380dd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CRBU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507543782","title":"Caribou Biosciences, Inc.盘中异动 早盘大幅下挫5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507543782","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507543782?lang=zh_cn&edition=full","pubTime":"2025-01-29 00:21","pubTimestamp":1738081274,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日00时21分，Caribou Biosciences, Inc.股票出现波动，股价快速下跌5.41%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Caribou Biosciences, Inc.公司简介：Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats  生物制药公司，致力于通过应用其新型 CRISPR 平台， CRISPR 杂交 RNA-DNA  来改变患有毁灭性疾病患者的生活，以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129002114987577d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129002114987577d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CRBU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506583806","title":"Caribou Biosciences, Inc.盘中异动 快速下跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506583806","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506583806?lang=zh_cn&edition=full","pubTime":"2025-01-28 02:03","pubTimestamp":1738000993,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日02时03分，Caribou Biosciences, Inc.股票出现波动，股价快速跳水5.30%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。Caribou Biosciences, Inc.公司简介：Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats  生物制药公司，致力于通过应用其新型 CRISPR 平台， CRISPR 杂交 RNA-DNA  来改变患有毁灭性疾病患者的生活，以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280203149874cf8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280203149874cf8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBU","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503470916","title":"Caribou Biosciences, Inc.盘中异动 早盘快速拉升5.13%报1.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503470916","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503470916?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:30","pubTimestamp":1736951457,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时30分，Caribou Biosciences, Inc.股票出现波动，股价大幅上涨5.13%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Os Therapies Incorporated、Generation Bio Co.、Exicure, Inc.涨幅较大，Windtree Therapeutics, Inc.、Os Therapies Incorporated、Phio Pharmaceuticals Corp.较为活跃，换手率分别为183.27%、53.42%、49.93%，振幅较大的相关个股有Vincerx Pharma, Inc.、Onconetix, Inc.、Cibus, Inc.，振幅分别为10.72%、9.31%、7.58%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223057ababf1bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223057ababf1bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CRBU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503570928","title":"Caribou Biosciences, Inc.盘中异动 股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503570928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503570928?lang=zh_cn&edition=full","pubTime":"2025-01-14 23:09","pubTimestamp":1736867360,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日23时09分，Caribou Biosciences, Inc.股票出现波动，股价大幅上涨5.16%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Caribou Biosciences, Inc.公司简介：Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats  生物制药公司，致力于通过应用其新型 CRISPR 平台， CRISPR 杂交 RNA-DNA  来改变患有毁灭性疾病患者的生活，以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011423092098660a5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011423092098660a5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","CRBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503586877","title":"Caribou Biosciences, Inc.盘中异动 股价大跌5.18%报1.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503586877","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503586877?lang=zh_cn&edition=full","pubTime":"2025-01-13 23:04","pubTimestamp":1736780692,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日23时04分，Caribou Biosciences, Inc.股票出现异动，股价急速下挫5.18%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.33%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为6179.88%、3584.88%、408.67%，振幅较大的相关个股有Kairos Pharma, Ltd.、Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.，振幅分别为124.54%、121.30%、104.79%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113230452960259a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113230452960259a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRBU","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502860484","title":"Caribou Biosciences, Inc.盘中异动 早盘股价大跌5.23%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502860484","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502860484?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:53","pubTimestamp":1736520789,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时53分，Caribou Biosciences, Inc.股票出现异动，股价快速下挫5.23%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.99%。其相关个股中，Conduit Pharmaceuticals Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 、Precision Biosciences, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃，换手率分别为1073.27%、188.31%、182.42%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.、Zyversa Therapeutics, Inc.，振幅分别为45.98%、41.78%、37.29%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102253099861ee17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102253099861ee17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","CRBU"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cariboubio.com","stockEarnings":[{"period":"1week","weight":-0.0161},{"period":"1month","weight":-0.2375},{"period":"3month","weight":-0.3297},{"period":"6month","weight":-0.3711},{"period":"1year","weight":-0.4529},{"period":"ytd","weight":-0.2327}],"compareEarnings":[{"period":"1week","weight":-0.0022},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1735},{"period":"1year","weight":0.1501},{"period":"ytd","weight":0.1286}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Caribou Biosciences, Inc.于2011年10月在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，专注于利用其专有的chRDNA基因组编辑技术开发用于血液恶性肿瘤的异体CAR-T细胞疗法。其主要候选药物vispacabtagene regedleucel (vispa-cel) 和 CB-011 旨在作为现货型产品提供广泛的患者可及性和快速治疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.056975},{"month":2,"riseRate":0.4,"avgChangeRate":0.046168},{"month":3,"riseRate":0,"avgChangeRate":-0.1556},{"month":4,"riseRate":0,"avgChangeRate":-0.151305},{"month":5,"riseRate":0.8,"avgChangeRate":0.089141},{"month":6,"riseRate":0.2,"avgChangeRate":-0.176107},{"month":7,"riseRate":0.8,"avgChangeRate":0.40849},{"month":8,"riseRate":0.5,"avgChangeRate":0.103455},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.043986},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.065307},{"month":11,"riseRate":0.4,"avgChangeRate":0.066546},{"month":12,"riseRate":0,"avgChangeRate":-0.198393}],"exchange":"NASDAQ","name":"Caribou Biosciences","nameEN":"Caribou Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Caribou Biosciences(CRBU)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Caribou Biosciences(CRBU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Caribou Biosciences,CRBU,Caribou Biosciences股票,Caribou Biosciences股票老虎,Caribou Biosciences股票老虎国际,Caribou Biosciences行情,Caribou Biosciences股票行情,Caribou Biosciences股价,Caribou Biosciences股市,Caribou Biosciences股票价格,Caribou Biosciences股票交易,Caribou Biosciences股票购买,Caribou Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Caribou Biosciences(CRBU)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Caribou Biosciences(CRBU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}